Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Liliana Elena D'agostino, Fernando Ventimiglia, Juan Antonio Verna, Amelia De La Colina, Yanina Aguirre, Alfredo Arturi & Alberto Capparelli. (2013) Correlation between DAS-28 and neopterin as a biochemical marker of immune system activation in early rheumatoid arthritis. Autoimmunity 46:1, pages 44-49.
Read now
Read now
H. Guler, A. D. Turhanoglu, B. Ozer, C. Ozer & A. Balci. (2008) The relationship between anti‐cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 37:5, pages 337-342.
Read now
Read now
Articles from other publishers (33)
I Gessl, P.V Balint, E Filippucci, H.I Keen, C Pineda, L Terslev, B Wildner, M.A D'Agostino & P Mandl. (2021) Structural damage in rheumatoid arthritis assessed by musculoskeletal ultrasound: A systematic literature review by the Structural Joint Damage Task Force of the OMERACT Ultrasound Working Group. Seminars in Arthritis and Rheumatism 51:3, pages 627-639.
Crossref
Crossref
Lieh-Bang Liou & Che-Ching Huang. (2020) Reverse expression of α2,6-sialic acid ratios on IgG, IgM, and IgG/IgM autoantibodies correlates with mouse arthritis and rheumatoid arthritis disease activity. Journal of the Chinese Medical Association 83:12, pages 1079-1086.
Crossref
Crossref
Minglu YanJianling SuYang Li. (2020) Rheumatoid arthritis-associated bone erosions: evolving insights and promising therapeutic strategies. BioScience Trends 14:5, pages 342-348.
Crossref
Crossref
Shadia I. Allam, Rehab A. Sallam, Doaa M. Elghannam & Atif I. El-Ghaweet. (2019) Clinical significance of serum B cell chemokine (CXCL13) in early rheumatoid arthritis patients. The Egyptian Rheumatologist 41:1, pages 11-14.
Crossref
Crossref
Lílian Santuza Santos Porto, Wilson Campos TavaresJúniorJúnior, Dário Alves da Silva Costa, Cristina Costa Duarte Lanna & Adriana Maria Kakehasi. (2017) Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study. Revista Brasileira de Reumatologia (English Edition) 57:1, pages 15-22.
Crossref
Crossref
Lílian Santuza Santos Porto, Wilson Campos Tavares Júnior, Dário Alves da Silva Costa, Cristina Costa Duarte Lanna & Adriana Maria Kakehasi. (2017) O anti‐CCP não é um marcador de gravidade da artrite reumatoide estabelecida: um estudo de ressonância magnética. Revista Brasileira de Reumatologia 57:1, pages 15-22.
Crossref
Crossref
Irandokht SHENAVAR MASOOLEH, Asghar HAJIABBASI, Habib ZAYENI, Atefeh GHANBARI, Violet ZAKER ESTEGHAMATI, Banafsheh GHAVIDEL PARSA & Amir HASSANKHANI. (2016) Anticyclic citrullinated peptide antibody in rheumatoid arthritis:a cross-sectional study in Iran. TURKISH JOURNAL OF MEDICAL SCIENCES 46, pages 1309-1313.
Crossref
Crossref
Pulukool Sandhya, Debashish Danda, Disha Sharma & Vinod Scaria. (2016) Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis. International Journal of Rheumatic Diseases 19:1, pages 8-20.
Crossref
Crossref
Naglaa GadAllah, Mona Elhossieny, Nouran Abaza, Shahdan Yousry & Samah A. El-Bakry. (2015) Verification of an ultrasonographic scoring system in discriminating rheumatoid arthritis from osteoarthritic and normal joints in an Egyptian cohorts. Egyptian Rheumatology and Rehabilitation 42:1, pages 19-26.
Crossref
Crossref
A. A. Jilani & C. G. Mackworth-Young. (2015) The Role of Citrullinated Protein Antibodies in Predicting Erosive Disease in Rheumatoid Arthritis: A Systematic Literature Review and Meta-Analysis. International Journal of Rheumatology 2015, pages 1-8.
Crossref
Crossref
Gaël Mouterde, Cédric Lukas, Philippe Goupille, René-Marc Flipo, Nathalie Rincheval, Jean-Pierre Daurès & Bernard Combe. (2014) Association of Anticyclic Citrullinated Peptide Antibodies and/or Rheumatoid Factor Status and Clinical Presentation in Early Arthritis: Results from the ESPOIR Cohort. The Journal of Rheumatology 41:8, pages 1614-1622.
Crossref
Crossref
Qianwen Lv, Yufeng Yin, Xin Li, Guangliang Shan, Xiangni Wu, Di Liang, Yongzhe Li & Xuan Zhang. (2014) The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated with the Effect of Anti-TNFα Agent Treatment in Patients with Rheumatoid Arthritis: A Meta-Analysis. PLoS ONE 9:2, pages e89442.
Crossref
Crossref
Martha Lucía González Arboleda, Jorge Rueda Gutiérrez, Herman González Buriticá & Mercedes Salcedo Cifuentes. (2013) Utilidad diagnóstica del anticuerpo antipéptido cíclico citrulinado como prueba diagnóstica en pacientes con artritis reumatoide. Revista Colombiana de Reumatología 20:1, pages 9-18.
Crossref
Crossref
Seung Woo Han, Keum Hee Sa, Sung Il Kim, Sang Il Lee, Yong Wook Park, Shin Seok Lee, Wan Hee Yoo, Jin Young Kang, Jae Seok Soe, Eon Jeong Nam, Jongmin Lee, Jae Yong Park & Young Mo Kang. (2012) FCRL3 gene polymorphisms contribute to the radiographic severity rather than susceptibility of rheumatoid arthritis. Human Immunology 73:5, pages 537-542.
Crossref
Crossref
Jun Liao, Wai-sze Ip, Kwan-yee Cheung, Wai-man Wan, George W.H. Cautherley, Xiaoyan Cai, Xiaojun Lin, Reinhard Renneberg & Cangel Pui-yee Chan. (2011) Diagnostic utility of an anti-CCP point-of-care immunotest in Chinese patients with rheumatoid arthritis. Clinica Chimica Acta 412:9-10, pages 778-781.
Crossref
Crossref
Peter Taylor, Juliane Gartemann, Jeanie Hsieh & James Creeden. (2011) A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis. Autoimmune Diseases 2011, pages 1-18.
Crossref
Crossref
Altan Ercan, Jing Cui, Dereck E. W. Chatterton, Kevin D. Deane, Melissa M. Hazen, William Brintnell, Colin I. O'Donnell, Lezlie A. Derber, Michael E. Weinblatt, Nancy A. Shadick, David A. Bell, Ewa Cairns, Daniel H. Solomon, V. Michael Holers, Pauline M. Rudd & David M. Lee. (2010) Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis & Rheumatism 62:8, pages 2239-2248.
Crossref
Crossref
Hyun Hee KimJiHun KimSung-Hoon ParkSeong-Kyu KimOk-Dong KimJung-Yoon Choe. (2010) Correlation of Anti-Cyclic Citrullinated Antibody with Hand Joint Erosion Score in Rheumatoid Arthritis Patients. The Korean Journal of Internal Medicine 25:2, pages 201.
Crossref
Crossref
Yi Zhao, Jing Li, Xiao-xia Li, Chun Li, Lin Li & Zhan-guo Li. (2009) Anticorps anti-peptides cycliques citrullinés dans le lupus érythémateux systémique. Revue du Rhumatisme 76:9, pages 873-880.
Crossref
Crossref
Yi Zhao, Jing Li, Xiao-xia Li, Chun Li, Lin Li & Zhan-guo Li. (2009) What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?. Joint Bone Spine 76:5, pages 501-507.
Crossref
Crossref
Ted R. Mikuls, Jeffrey B. Payne, Richard A. Reinhardt, Geoffrey M. Thiele, Eileen Maziarz, Amy C. Cannella, V. Michael Holers, Kristine A. Kuhn & James R. O'Dell. (2009) Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. International Immunopharmacology 9:1, pages 38-42.
Crossref
Crossref
Walther J. Van Venrooij, Joyce J.B.C. Van Beers & Ger J.M. Pruijn. (2008) Anti‐CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. Annals of the New York Academy of Sciences 1143:1, pages 268-285.
Crossref
Crossref
M. Bukhari, W. Thomson, H. Naseem, D. Bunn, A. Silman, D. Symmons & A. Barton. (2007) The performance of anti–cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: Results from the Norfolk Arthritis Register. Arthritis & Rheumatism 56:9, pages 2929-2935.
Crossref
Crossref
Sung-Hoon ParkJi-Young KimSeong-Kyu KimJung-Yoon ChoeSang Kyung KimIm-Hee Shin. (2007) Diagnostic Significance of Anti-CCP Antibody in Korean Early Rheumatoid Arthritis. The Journal of the Korean Rheumatism Association 14:3, pages 227.
Crossref
Crossref
S. Kaltenhäuser, M. Pierer, S. Arnold, M. Kamprad, C. Baerwald, H. Häntzschel & U. Wagner. (2007) Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis. Rheumatology 46:1, pages 100-104.
Crossref
Crossref
Walther J. van Venrooij, Albert J.W. Zendman & Ger J.M. Pruijn. (2006) Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmunity Reviews 6:1, pages 37-41.
Crossref
Crossref
Lisa GM van Baarsen, Tineke CTM van der Pouw-Kraan & Cornelis L Verweij. (2006) A genomic view of subtypes in rheumatoid arthritis: towards personalized medicine. Future Rheumatology 1:3, pages 311-322.
Crossref
Crossref
Rudolf Mierau & Ekkehard Genth. (2006) Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis. Clinical Chemistry and Laboratory Medicine (CCLM) 44:2.
Crossref
Crossref
A. J. W. Zendman, W. J. van Venrooij & G. J. M. Pruijn. (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 45:1, pages 20-25.
Crossref
Crossref
Cornelis L. Verweij & Tineke C. T. M. van der Pouw Kraan. 2006. The Hereditary Basis of Rheumatic Diseases. The Hereditary Basis of Rheumatic Diseases
29
42
.
Evan Romas. (2005) Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates. Best Practice & Research Clinical Rheumatology 19:6, pages 1065-1079.
Crossref
Crossref
Rudolf Mierau & Ekkehard Genth. (2005) Diagnostik und Prognostik der frühen rheumatoiden Arthritis unter besonderer Berücksichtigung der Labor-Analytik Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis. LaboratoriumsMedizin 29:4, pages 251-256.
Crossref
Crossref
M. Herold, V. Boeser, E. Russe & W. Klotz. (2005) Anti-CCP: History and its Usefulness. Clinical and Developmental Immunology 12:2, pages 131-135.
Crossref
Crossref